HLB Life Science Co. Ltd (067630) — Capital Reinvestment Ratio
HLB Life Science Co. Ltd (067630) has a Capital Reinvestment Ratio of 0.99x as of March 2023, meaning it reinvests 1% of its operating cash flow (₩3.55 Billion) in capital expenditures (₩3.52 Billion). See debt-free asset ratio of HLB Life Science Co. Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HLB Life Science Co. Ltd Capital Reinvestment Ratio (2012–2020)
This chart tracks HLB Life Science Co. Ltd's Capital Reinvestment Ratio across 4 annual periods. Check HLB Life Science Co. Ltd (067630) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for HLB Life Science Co. Ltd (2012–2020)
Year-by-year Capital Reinvestment Ratio for HLB Life Science Co. Ltd from 2012 to 2020. For live market cap and broader valuation context, see HLB Life Science Co. Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 4.18x | ₩2.01 Billion | ₩8.41 Billion | ▲ +18377.9% |
| 2014 | 0.02x | ₩10.43 Billion | ₩236.21 Million | ▲ +29.7% |
| 2013 | 0.02x | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩13.97 Billion | ₩9.18 Billion | — |